IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Anavex Life Sciences COR

CUSIP: 032797102 | 4 institutional holders

Quarters

Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2025

Byrne Asset Management LLC6,400
0.0% of portfolio›$57.0K
StyleTurnoverLocationFiled
Byrne Asset Management LLC
6,400$57.0K0.0%CoreLowKingston, NJ2025-10-22